Description: Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, together with its subsidiaries, engages in the research, development, production, and marketing of pharmaceutical products primarily in the United States, Canada, and Israel. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas comprising topical creams and ointments, liquids, capsules, and tablets principally in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. Taro Pharmaceutical Industries Ltd. sells and distributes its products to drug wholesalers and store chains, generic drug distributors, mass merchandisers, food and retail chains, and managed care organizations. The company was founded in 1959 and is based in Haifa Bay, Israel.
Home Page: www.taro.com
TARO Technical Analysis
14 Hakitor Street
Haifa,
2624761
Israel
Phone:
972 4 847 5700
Officers
Name | Title |
---|---|
Mr. Uday V. Baldota | CEO & Director |
Mr. William J. Coote | VP, CFO & Chief Accounting Officer |
Mr. Itamar Karsenti | VP & Head of Operations |
Mr. Avi Avramoff | VP and Head of R&D |
Mr. Itzik Baruch | VP of Technical Services |
Dr. Roman Kaplan | VP of Scientific and Technical Compliance Mang. |
Mr. Erik Zwicker J.D. | VP, Gen. Counsel & Sec. |
Mr. Ara Aprahamian | VP of Sales & Marketing |
Ms. Michele Visosky | VP & Head of Human Resource |
Mr. Jayesh Shah | Head of Procurement |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 9.8135 |
---|---|
Trailing PE: | 16.7529 |
Price-to-Book MRQ: | 0.7446 |
Price-to-Sales TTM: | 1.9102 |
IPO Date: | 1993-04-01 |
Fiscal Year End: | March |
Full Time Employees: | 1455 |